Terrillion Scott M.'s most recent trade in Tvardi Therapeutics Inc. was a trade of 163 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Scott M. Terrillion | SECY; CHIEF COMPLIANCE & G.C. | Sale of securities on an exchange or to another person at price $ 4.76 per share. | 28 Feb 2025 | 163 | 7,190 (0%) | 0% | 4.8 | 776 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | SECY; CHIEF COMPLIANCE & G.C. | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 05 Apr 2024 | 2,753 | 88,247 (0%) | 0% | 0.8 | 2,285 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | SECY; CHIEF COMPLIANCE & G.C. | Sale of securities on an exchange or to another person at price $ 0.89 per share. | 29 Feb 2024 | 3,293 | 91,000 (0%) | 0% | 0.9 | 2,931 | Common Stock |
| Tvardi Therapeutics Inc | Terrillion Scott M. | SECY; CHIEF COMPLIANCE & G.C. | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 08 Feb 2024 | 7,770 | 94,293 (0%) | 0% | 0.5 | 4,118 | Common Stock |
| Tvardi Therapeutics Inc | Scott Terrillion M. | SECY; CHIEF COMPLIANCE & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 13,500 | 102,063 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 3.51 per share. | 23 Jun 2023 | 2,483 | 88,563 (0%) | 0% | 3.5 | 8,715 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 4.91 per share. | 04 Apr 2023 | 2,481 | 91,046 (0%) | 0% | 4.9 | 12,182 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 9.71 per share. | 03 Mar 2023 | 6,256 | 93,527 (0%) | 0% | 9.7 | 60,746 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 81,000 | 81,000 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 11.27 per share. | 21 Dec 2022 | 2,561 | 99,783 (0%) | 0% | 11.3 | 28,862 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 11.91 per share. | 01 Apr 2022 | 1,642 | 102,344 (0%) | 0% | 11.9 | 19,556 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 03 Mar 2022 | 1,787 | 103,986 (0%) | 0% | 11.4 | 20,336 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 20,000 | 102,412 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 5,333 | 105,773 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 10.29 per share. | 25 Feb 2022 | 1,972 | 100,440 (0%) | 0% | 10.3 | 20,292 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 30 Aug 2021 | 1,759 | 70,917 (0%) | 0% | 14.2 | 24,978 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2021 | 5,334 | 72,676 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 32,000 | 32,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 16,000 | 67,342 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 10,000 | 54,432 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 17.98 per share. | 04 Mar 2021 | 3,090 | 51,342 (0%) | 0% | 18.0 | 55,558 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 6,000 | 48,436 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 19.33 per share. | 23 Feb 2021 | 4,004 | 44,432 (0%) | 0% | 19.3 | 77,397 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 30 Dec 2020 | 1,946 | 42,436 (0%) | 0% | 15.3 | 29,774 | Common Stock |
| Tvardi Therapeutics Inc | Scott M. Terrillion | Secy; Chief Compliance & G.C. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2020 | 6,000 | 44,382 (0%) | 0% | 0 | Common Stock |